Papillomaviruses (linked to cervical cancer when they infect the mucosal tissue in the female reproductive tract) can also infect normal skin, where they cause warts and possibly non-melanoma skin cancer, mostly in immune-suppressed ...
Feb 20, 2014
1
0
Many vaccines, including those for influenza, polio, and measles, consist of a killed or disabled version of a virus. However, for certain diseases, this type of vaccine is ineffective, or just too risky.
Feb 17, 2014
0
0
Preliminary results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself. The Johns Hopkins scientists ...
Jan 29, 2014
0
0
Gene related to the proliferation of cancerous cells blocked through molecular technology.
Jan 28, 2014
0
0
Women previously treated for abnormal cells on the cervix (CIN3 or cervical intraepithelial neoplasia grade 3) are at an increased risk of developing and dying from cervical or vaginal cancer compared with the general female ...
Jan 14, 2014
0
0
Two existing drugs – one the active ingredient in an anti-fungal medication and the other now used to control iron levels in the blood – both show promise as potential treatments for cervical cancer, according to newly ...
Dec 16, 2013
0
0
In the past few years, there have been dramatic advances in the use of genomic analysis, molecular biology, imaging technologies and data management to make cancer treatment less toxic and better tailored to individual patients.
Nov 18, 2013
0
0
A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type's molecular idiosyncrasies.
Aug 23, 2013
0
0
A team from the University of Washington has unveiled a comprehensive portrait of the genome of the world's first immortal cell line, known as HeLa. The cell line was derived in 1951 from an aggressive cervical cancer that ...
Aug 7, 2013
0
0
The human papillomavirus (HPV) triples the risk of people developing yet another cancer, oesophageal squamous cell carcinoma (OSCC), according to research led by University of New South Wales (UNSW) academics.
Jul 24, 2013
0
0
